Recent advances and developments in the clinical use of i.v. opioids during the peroperative period

British Journal of Anaesthesia

Volumn 81, Issue 1, 1998, Pages 38-50

  Sear, J W ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Kidney, disease; Liver, disease; Pharmacodynamics, anaesthetics opioid; Pharmacokinetics, anaesthetics opioid; Pharmacology, anaesthetics opioid

Indexed keywords

ALFENTANIL; FENTANYL; MIRFENTANIL; MORPHINE; OPIATE; PETHIDINE; PIPERIDINE DERIVATIVE; REMIFENTANIL; SUFENTANIL; TRAMADOL; TREFENTANIL;

ANALGESIA; BALANCED ANESTHESIA; GENERAL ANESTHESIA; HUMAN; INTRAOPERATIVE PERIOD; INTRAVENOUS ANESTHESIA; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; LIVER DISEASE; PRIORITY JOURNAL; REVIEW;

EID: 0031851519     PISSN: 00070912     EISSN: None     Source Type: Journal    
DOI: 10.1093/bja/81.1.38     Document Type: Review

References (134)

1. Adams AP, Pybus DA. Delayed respiratory depression after use of fentanyl during anaesthesia. British Medical Journal 1976; i: 278-279.
2. Aitkenhead AR, Vater M, Achola K, Cooper CMS, Smith G. Pharmacokinetics of single-dose i.v. morphine in normal volunteers and patients with end-stage renal failure. British Journal of Anesthesia 1984; 56: 813-818.
3. Andrews CJH, Sinclair M, Prys-Roberts C, Dye A. Ventilatory effects during and after continuous infusion of fentanyl or alfentanil. British Journal of Anaesthesia 1983; 55 (suppl. 2): 211s-216s.
4. Ausems ME, Hug CC jr, Stanski DR, Burm AGL. Plasma concentrations of alfentanil required to supplement nitrous oxide anesthesia for general surgery. Anesthesiology 1986; 65: 362-373.
5. Ausems ME,Vuyk J, Hug CC jr, Stanski DR. Comparison of a computer-assisted infusion versus intermittent bolus administration of alfentanil as a supplement to nitrous oxide for lower abdominal surgery. Anesthesiology 1988; 68: 851-861.
6. Austin KL, Stapleton JV, Mather LE. Relationship between blood meperidine concentrations and analgesic response. Anesthesiology 1980; 53: 460-466.
7. Bacon R, Chandrasekan V, Haigh A, Royston BD, Royston D, Sundt T. Early extubation after open-heart surgery with total intravenous anaesthetic technique. Lancet 1995; 345: 133-134.
8. Bailey P, Gerbode F, Garlington L. An anesthetic technique for cardiac surgery which utilizes 100% oxygen as the only inhalant. Archives of Surgery 1958; 76: 437-443.
9. Bartkowski RR, Goldberg ME, Larijani GE, Boerner T. Inhibition of alfentanil metabolism by erythromycin. Clinical Pharmacology and Therapeutics 1989; 46: 99-102.
10. Bartkowski RR, McDonnell TE. Prolonged alfentanil effect following erythromycin administration. Anesthesiology 1990; 73: 566-568.
11. Becker LD, Paulson BA, Miller RD, Severinghaus JW, Eger EI. Biphasic respiratory depression after fentanyl-droperidol or fentanyl alone used to supplement nitrous oxide anesthesia. Anesthesiology 1976; 44: 291-296.
12. Benefiel DJ, Roizen MF. Opioids and outcome in peripheral vascular surgery. In: Estafanous FG, ed. Opioids in anesthesia. Stoneham, MA: Butterworth-Heinemann 1991; chapter 11, 129-138.
13. Bodenham A, Quinn K, Park GR. Extrahepatic morphine metabolism in man during the anhepatic phase of orthotopic liver transplantation. British Journal of Anaesthesia 1989; 63: 380-384.
14. Bovill JG, Sebel PS, Blackburn CL, Oei-Lim V, Heykants JJ. The pharmacokinetics of sufentanil in surgical patients. Anesthesiology 1984; 61: 502-506.
15. Bower S. Plasma protein binding of fentanyl: the effect of hyperlipidaemia and chronic renal failure. Journal of Pharmacy and Pharmacology 1982; 34102-106.
16. Bower S, Sear JW. Disposition of alfentanil in patients receiving a renal transplant. Journal of Pharmacy and Pharmacology 1989; 41: 654-657.
17. Bower S, Sear JW, Roy RC, Carter RF. Effects of different hepatic pathologies on disposition of alfentanil in anaesthetized patients. British Journal of Anaesthesia 1992; 68: 462-465.
18. Brunner MD, Braithwaite P, Jhaveri R. MAC reduction of isoflurane by sufentanil. British Journal of Anaesthesia 1994; 72: 42-46.
19. Cambareri JJ, Afifi MS, Glass PSA, Esposito BF, Camporesi EM. A-3665, a new short-acting opioid: a comparison with alfentanil. Anesthesia and Analgesia 1993; 76: 812-816.
20. Chan K, Tse J, Jenning F, Orme ML. Pharmacokinetics of low-dose intravenous pethidine in patients with renal dysfunction. Journal of Clinical Pharmacology 1987; 27: 516-522.
21. Chauvin M, Lebrault C, Levron JC, Duvaldestin P. Pharmacokinetics of alfentanil in chronic renal failure. Anesthesia and Analgesia 1987; 66: 53-56.
22. Chauvin M, Sandouk P, Scherrmann JM, Farinotti R, Strumza P, Duvaldestin P. Morphine pharmacokinetics in renal failure. Anesthesiology 1987; 66: 327-331.
23. Coda BA, Bohl S, Schaffer RL, Shen DD. Morphine analgesia in normal volunteers; the role of morphine-6-glucuronide (abstract). Anesthesiology 1996; 83: A884.
24. Corall IM, Moore AR, Strunin L. Plasma concentrations of fentanyl in normal surgical patients and those with severe renal and hepatic disease (abstract). British Journal of Anaesthesia 1980; 52: 101p.
25. Cork RC, Behr SE, Depa R, Kramer TH. Hemodynamic effects of mirfentanil for conscious sedation (abstract). Anesthesiology 1992; 77: A39.
26. Cork RC, Behr SE, Kramer TH, Kihlstrom J. Sedative and amnesic effects of mirfentanil for conscious sedation (abstract). Anesthesiology 1992; 77: A178.
27. Covington EC, Gonsalves-Ebrahim L, Currie KO, Shepard KV, Pippenger CE. Severe respiratory depression from patient-controlled analgesia in renal failure. Psychosomatics 1989; 30: 226-228.
28. Crotty B, Watson KJR, Desmond PV, Mashford ML, Wood LJ, Colman J, Dudley FJ. Hepatic extraction of morphine is impaired in cirrhosis. European Journal of Clinical Pharmacology 1989; 36: 501-506.
29. Dahlstrom B, Tamsen A, Paalzow L, Hartvig P. Patient-controlled analgesic therapy, Part IV; pharmacokinetics and plama concentrations of morphine. Clinical Pharmacokinetics 1982; 7: 266-279.
30. Davis PJ, Stiller RL, Cook DR, Brandom BW, Davin-Robinson KA. Pharmacokinetics of sufentanil in adolescent patients with chronic renal failure. Anesthesia and Analgesia 1988; 67: 268-271.
31. 2 for coronary artery surgery. Anesthesiology 1982; 56: 112-118.
32. Dershwitz M, Hoke JF, Rosow CE, Michalowski P, Connors PM, Muir KT, Dienstag JL. Pharmacokinetics and pharmacodynamics of remifentanil in volunteer subjects with severe liver disease. Anesthesology 1996; 84: 812-820.
33. Don HF, Dieppa RA, Taylor P. Narcotic analgesics in anuric patients. Anesthesiology 1975; 42: 745-747.
34. Duthie DJR. Renal failure, surgery and fentanyl pharmacokinetics. Abstracts of VII European Congress of Anaesthesiology, volume I. In: Beitrage zur Anaesthesiologie und Intensivmedizin 1986; 16: 187.
35. Duthie DJR, Stevens JJWM, Doyle AR, Baddoo HHK. Remifentanil and coronary artery surgery. Lancet 1997; 345: 649-650.
36. Egan TD, Lemmens HJM, Fiset P, Hermann DJ, Muir KT, Stanski DR, Shafer SL. The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers. Anesthesiology 1993; 79: 881-892.
37. Egan TD, Minto C, Hermann DJ, Barr J, Muir KT, Shafer SL. Remifentanil versus alfentanil: comparative pharmacokinetics and pharmacodynamics in healthy adult male volunteers. Anesthesiology 1996; 84: 821-833.
38. Eggers KA, Power I. Tramadol. British Journal of Anaesthesia 1995; 74: 247-249.
39. Fragen RJ, Booij LHD, Braak GJJ, Vree TB, Heykants J, Crul JF. Pharmacokinetics of the infusion of alfentanil in man. British Journal of Anaesthesia 1983; 55: 1077-1081.
40. Fyman P, Reynolds J, Moser F, Avitable M, Casthley P, Butt K. Pharmacokinetics of sufentanil in patients undergoing renal transplantation. Canadian Journal of Anaesthesia 1988; 35: 312-315.
41. Gepts E, Shafer SL, Camu F, Stanski DR, Woestenborghs R, Van Peer A, Heykants JJ. Linearity of pharmacokinetics and model estimation of sufentanil. Anesthesiology 1995; 83: 1194-1204.
42. Glare PA, Walsh, Pippenger CE. Normorphine, a neurotoxic metabolite? Lancet 1990; 335: 725-726.
43. Glass PSA. Remifentanil: a new opioid. Journal of Clinical Anesthesia 1995; 7: 558-563.
44. Glass PSA, Doherty MA, Jacobs JR, Goodman DK, Reves JG. CP50 for sufentanil (abstract). Anesthesiology 1990; 73: A378
45. Gourlay GK, Willis RJ, Lamberty J. A double-blind comparison of the efficacy of methadone and morphine in postoperative pain control. Anesthesiology 1986; 64: 322-327.
46. Grace D, Fee JP. A comparison of intrathecal morphine-6-glucuronide and intrathecal morphine sulphate as analgesics for total hip replacement. Anesthesia and Analgesia 1996; 83: 1055-1059.
47. Graves DA, Arrigo JM, Foster TS, BaumannTJ, Batenhorst RL. Relationship between plasma morphine concentrations and pharmacological effects in postoperative patients using patient-controlled analgesia. Clinical Pharmacy 1985; 4: 41-47.
48. Gulden D, Koehntop D, Rodman J, Brundage D, Hegland M. Fentanyl pharmacokinetics during renal transplantation (abstract). Anesthesiology 1984; 61: A243.
49. Guy J, Hindman BJ, Baker KZ, Borel CO, Maktabi M, Ostapkovich N, Kirchner J, Todd MM, Fohgarty-Mack P, Yancy V, Sokoll MD, McAllister A, Roland C, Young WL, Warner DS. Comparison of remifentanil and fentanyl in patients undergoing craniotomy for supratentorial space-occupying lesions. Anesthesiology 1997; 86: 514-524.
50. Haberer JP, Schoeffler E, Couderc E, Duvaldestin P. Fentanyl pharmacokinetics in anaesthetized patients with cirrhosis. British Journal of Anaesthesia 1982; 54: 1267-1270.
51. Hengstmann JH, Stoeckel H, Schuttler J. Infusion model for fentanyl based on pharmacokinetic analysis. British Journal of Anaesthesia 1980; 52: 1021-1025.
52. Hoke JF, Cunningham F, James MK, Muir KT, Hoffman WE. Comparative pharmacokinetics and pharmacodynamics of remifentanil, its principle metabolite (GR90291) and alfentanil in dogs. Journal of Pharmacology and Experimental Therapeutics 1997; 281: 226-232.
53. Hoke JF, Schlugman D, Dershwitz M, Michalowski P, Malthouse-Dufore S, Connors PN, Martel D, Rosow CE, Muir KT, Rubin N, Glass PSA. Pharmacokinetics and pharmacodynamics of remifentanil in persons with renal failure compared with healthy volunteers. Anesthesiology 1997; 87: 533-541.
54. Howie MB, Kelly WB, Porembka DT, Warren SA, Cain SR, Kirkhart BA. Catecholamine response during CABG with remifentanil anesthesia (abstract). Anesthesia and Analgesia 1996; 82: s189.
55. Hudson RJ, Bergstrom RG, Thompson IR, Sabonrin MA, Rosenbloom M, Strunin L. Pharmacokinetics of sufentanil in patients undergoing abdominal aortic surgery. Anesthesiology 1989; 70; 426-431.
56. Hudson RJ, Thompson IR, Cannon JE, Friesen PM, Meatherall RC. Pharmacokinetics of fentanyl in patients undergoing abdominal aortic surgery. Anesthesiology 1986; 64: 334-338.
57. Huet P-M, Villeneuve J-P. Determinants of drug disposition in patients with cirrhosis. Hepatology 1983; 3: 913-919.
58. Hug CC jr, Hall RI, Angert KC, Reeder DA, Moldenhauer CC. Alfentanil plasma concentrations versus effect relationships in cardiac surgical patients. British Journal of Anaesthesia 1988; 68: 435-440.
59. Hughes MA, Glass PSA, Jacobs JR. Context-sensitive half-time in multicompartment pharmacokinetic models for intravenous anesthetic drugs. Anesthesiology 1992; 76: 334-341.
60. James MF, Heijke SA, Gordon PC. Intravenous tramadol versus epidural morphine for post-thoracotomy pain relief: a placebo-controlled double-blind trial. Anesthesia and Analgesia 1996; 83: 87-91.
61. Kharasch ED, Russell M, Mautz D, Thummel KE, Kunze KL, Bowdle A, Cox K.The role of cytochrome P450 3A4 in alfentanil clearance. Implications for interindividual variability in disposition and perioperative drug interactions. Anesthesiology 1997; 87: 36-50.
62. Kharasch ED, Thummel KE. Human alfentanil metabolism by cytochrome P450 3A3/4: an explanation for the interindividual variability in alfentani clearance? Anesthesia and Analgesia 1993; 76: 1033-1039.
63. Kissin I, Vinik HR, Castillo R, Bradley EI. Alfentanil potentiates midazolam-induced unconsciousness in subanesthetic doses. Anesthesia and Analgesia 1990; 71: 65-69.
64. Klotz U, McHorse TS, Wilkinson GR, Schenker S. The effects of cirrhosis on the disposition and elimination of meperidine in man. Clinical Pharmacology and Therapeutics 1974; 16: 667-675.
65. Kramer WG, Gross DR, Medlock. Contribution of the lung to total body clearance of meperidine in the dog. Journal of Pharmaceutical Sciences 1985; 74: 569-571.
66. Krane BD, Kreutz JM, Johnson DL, Mazuzan JE. Alfentanil and delayed respiratory depression: case studies and review. Anesthesia and Analgesia 1990; 70: 557-561.
67. Lang E, Kapila A, Schlugman D, Hoke JF, Sebel PS, Glass PSA. Reduction of isoflurane minimum alveolar concentration by remifentanil. Anesthesiology 1996; 85: 721-728.
68. Lemmens HJM, Bovill JG, Hennis PJ, Burm AGL. Age has no effect on the pharmacodynamics of alfentanil. Anesthesia and Analgesia 1988; 67: 956-960.
69. Lemmens HJM, Bovill JG, Hennis PJ, Gladines MPRR, Burm AGL. Alcohol consumption alters the pharmacodynamics of alfentanil. Anesthesiology 1989; 71: 669-674.
70. Lemmens HJM, Dyck JB, Shafer SL, Stanski DR. Pharmacokinetic-pharmacodynamic modeling in drug development: application to the investigational opioid trefentanil. Clinical Pharmacology and Therapeutics 1994; 56: 261-271.
71. Lemmens HJ, Egan TD, Fiset P, Stanski DR. Pharmacokinetic-pharmacodynamic assessment in drug development: application to the investigational opioid mirfentanil. Anesthesia and Analgesia 1995; 80: 1206-1211.
72. 3H] sufentanil, a superior ligand for μ -opiate receptors: binding properties and regional distribution in rat brain and spinal cord. European Journal of Pharmacology 1983; 87: 209-225.
73. Loetsch J, Stockmann A, Kobal G, Bruine K, Waibel R, Schmidt N, Geisslinger G. Pharmacokinetics of morphine and its glucuronides after intravenous infusion of morphine and morphine-6-glucuronide in healthy volunteers. Clinical Pharmacology and Therapeutics 1996; 60: 316-325.
74. Lowenstein E, Hallowell P, Levine FH, Daggett WM, Austin GA, Laver MB. Cardiovascular response to large doses of intravenous morphine in man. New England Journal of Medicine 1966; 281: 1389-1393.
75. Lu J, Glass PSA, Camporesi EM, Afifi MS, Quill TJ. The analgesic efficacy of A3508 compared to fentanyl (abstract). Anesthesiology 1990; 73: A835.
76. 50 of alfentanil for induction of anesthesia in unpremedicated young adults. Anesthesiology 1984; 60: 136-140.
77. McEwan AI, Smith C, Dyar O, Goodman D, Smith LR, Glass PSA. Isoflurane MAC reduction by fentanyl. Anesthesiology 1993; 78: 864-869.
78. Martin WK. Opioid antagonists. Pharmacological Reviews 1967; 19: 463-521.
79. Mazoit JX, Sandouk P, Zetlaoui P, Scherrmann JM. Pharmacokinetics of unchanged morphine in normal and cirrhotic subjects. Anesthesia and Analgesia 1987; 66: 293-298.
80. Mehta D, Bradley EI, Kissin I. Effect of alfentanil on hypnotic and antinociceptive components of thiopental sodium anesthesia. Journal of Clinical Anesthesia 1991; 3: 280-284.
81. Miller JW, Anderson HH. The effect of N-demethylation on certain pharmacologic actions of morphine, codeine and meperidine in the mouse. Journal of Pharmacology and Experimental Therapeutics 1954; 112: 191-196.
82. Mostert JW, Evers JL, Hobika GH, Moore RH, Ambrus JL. Cardiorespiratory effects of anaesthesia with morphine or fentanyl in chronic renal failure and cerebral toxicity after morphine. British Journal of Anaesthesia 1971; 43: 1053-1059.
83. Neal EA, Meffin PJ, Gregory PB, Blaschke TF. Enhanced bioavailability and decreased clearance of analgesics in patients with cirrhosis. Gastroenterology 1979; 77: 96-102.
84. Neff W, Mayer EC, de la Luz Perales M. Nitrous oxide and oxygen anesthesia with curare relaxation. California Medicine 1947; 66: 67-73.
85. Nilsson A, Tamsen A, Persson P. Midazolam-fentanyl anesthesia for major surgery. Plasma levels of midazolam during prolonged intravenous anesthesia. Acta Anaesthesiologica Scandinavica 1986; 30: 66-69.
86. O'Connor M, Sear JW. Sufentanil to supplement nitrous oxide in oxygen anaesthesia during balanced anaesthesia. Anaesthesia 1988; 43: 749-752.
87. Olsen GD, Bennett WM, Porter GA. Morphine and phenytoin binding to plasma proteins in renal and hepatic failure. Clinical Pharmacology and Therapeutics 1975; 17: 677-684.
88. Osborne R, Joel S, Grebenik K, Trew D, Slevin M. The pharmacokinetics of morphine and morphine glucuronides in kidney failure. Clinical Pharmacology and Therapeutics 1933; 54: 158-167.
89. Osborne RJ, Joel SP, Slevin ML. Morphine intoxication in renal failure: the role of morphine-6-glucuronide. British Medical Journal 1986; 292: 1548-1549.
90. Patwardhan RV, Johnson RF, Hoyumpa A, Sheeman JJ, Desmond PV, Wilkinson GR, Branch RA, Schenker S. Normal metabolism of morphine in cirrhosis. Gastroenterology 1981; 81: 1006-1011.
91. Persson MP. Hartvig P, Paalzow L. Pulmonary disposition of pethidine in postoperative patients. British Journal of Clinical Pharmacology 1988; 25: 235-241.
92. Persson MP, Nilsson A, Hartvig P. Pharmacokinetics of alfentanil in total i.v. anaesthesia. British Journal of Anaesthesia 1988; 60: 755-761.
93. Persson MP, Wiklund L, Hartvig P, Paalzow L. Potential pulmonary uptake and clearance of morphine in postoperative patients. European Journal of Clinical Pharmacology 1986; 30: 567-574.
94. Philbin DM, Rosow CE, Schneider RC, Koski G, D'Ambra MN. Fentanyl and sufentanil anesthesia revisited: how much is enough Anesthesiology 1990; 73: 5-11.
95. Pond SM, Tong T, Benowitz NL, Jacob P. Bioavailability and clearance of meperidine in patients with chronic liver disease (abstract). Clinical Pharmacology and Therapeutics 1979; 25: 242.
96. Pond SM, Tong T, Benowitz NL, Jacob P. Enhanced bioavailability of pethidine and pentazocine in patients with cirrhosis of the liver. Australian and New Zealand Journal of Medicine 1980; 10: 515-519.
97. Portenoy RK, Thaler HT, Inturnsi CE, Friedlander-Klar H, Foley KM. The metabolite morphine-6-glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function. Clinical Pharmacology and Therapeutics 1992; 51: 422-431.
98. Ralley FE, Murkin JM, Hudson RJ, Dunn G, Perrault L, Hardy JF. Alfentanil infusion for intra-abdominal surgery (abstract). Canadian Journal of Anaesthesia 1990; 37: s20
99. Ratclifife FM. Absence of morphine glucuronidation in the human lung. European Journal of Clinical Pharmacology 1989; 37: 537-538.
100. Reilly CS, Wood AJJ, Wood M. Variability of fentanyl pharmacokinetics in man. Computer predicted plasma concentrations for three intravenous dosage regimens. Anaesthesia 1985; 40: 837-843.
101. Richards MJ, Skues MA, Jarvis AP, Prys-Roberts C.Total i.v. anaesthesia with propofol and alfentanil: dose requirements for propofol and the effect of premedication with clonidine. British Journal of Anaesthesia 1990; 65: 157-163.
102. Robbins R, Whalley DG, Donati F. Altered pharmacokinetics of alfentanil. Canadian Anaesthetists Society Journal 1986; 33: s103-s104.
103. Roerig DL, Kotrly KJ, Vucins EJ, Ahlf SB, Dawson CA, Kampine JP. First pass uptake of fentanyl, meperidine and morphine in the human lung. Anesthesiology 1987; 67: 466-472.
104. Sawe J, Odar-Cederlof I. Kinetics of morphine in patients with renal failure. European Journal of Clinical Pharmacology 1987; 32: 377-382.
105. Schuttler J, Albrecht S, Breivik H, Osnes S, Prys-Roberts C, Holder K, Chauvin M, Viby-Mogensen J, Mogensen T, Gustafson I, Lof L, Noronha D, Kirkham AJT. A comparison of remifentanil and alfentanil in patients undergoing major abdominal surgery. Anaesthesia 1997; 52: 307-317.
106. Scott JC, Cooke JE, Stanski DR. Electroencephalographic quantitation of opioid effect: comparative pharmacodynamics of fentanyl and sufentanil. Anesthesiology 1991; 74: 34-42.
107. Scott JC, Ponganis KV, Stanski DR. EEG quantitation of narcotic effect: the comparative pharmacodynamics of fentanyl and alfentanil. Anesthesiology 1985; 62: 234-241.
108. Sear JW Disposition of fentanyl and alfentanil in patients undergoing renal transplantation. In: Bergmann H, Steinbereithner K, eds. VII European Congress of Anaesthesiology, Proceedings I (main topics 1-6). Beitrage zur Anaesthesiologie und Intensivmedizin 1987; 19: 53-58.
109. Sear JW. Sufentanil disposition in patients undergoing renal transplantation: influence of choice of kinetic model. British Journal of Anaesthesia 1989; 63: 60-67.
110. Sear JW. Kidney transplants: induction and analgesic agents. In: Royston D, Feeley, TW. Anesthesia for Patients with a Transplanted Organ. International Anesthesiology Clinics. Boston, MA: Little Brown and Company, 1995; 45-68.
111. Sear JW, Gavaghan D. Dynamic-kinetic relationships for sufentanil during nitrous oxide-oxygen anaesthesia (abstract). British Journal of Anaesthesia 1990; 65: 290p-291 p.
112. Sear JW, Hand CW, Moore RA, McQuay HJ. Studies on morphine disposition: influence of general anaesthesia on plasma concentrations of morphine and its metabolites. British Journal of Anaesthesia 1989; 62: 22-27.
113. Sear JW, Hand CW, Moore RA, McQuay HJ. Studies on morphine disposition: influence of renal failure on the kinetics of morphine and its metabolites. British Journal of Anaesthesia 1989; 62: 28-32.
114. Shafer A, Sung M-L, White PF. Pharmacokinetics and pharmacodynamics of alfentanil infusions during general anesthesia. Anesthesia and Analgesia 1986; 65: 1021-1028.
115. Shafer SL, Varvel JR. Pharmacokinetics, pharmacodynamics, and rational opioid selection. Anesthesiology 1991; 74: 53-63.
116. Short TG, Plummer JL, Chui PT. Hypnotic and anaesthetic interactions between midazolam, propofol and alfentanil. British Journal of Anaesthesia 1992; 69: 162-167.
117. Silbert BS, Rosow CE, Keegan CR, Latta WB, Murphy AL, Moss J, Philbin DM. The effect of diazepam on induction of anesthesia with alfentanil. Anesthesia and Analgesia 1986; 65: 71-77.
118. Sloan PA, Mather LE, McLean CF, Rutten AJ, Nation RL, Milne RW, Runciman WB, Somogyi AA. Physiological disposition of i.v. morphine in sheep. British Journal of Anaesthesia 1991; 67: 378-386.
119. 50 of propofol for loss of consciousness and skin incision. Anesthesiology 1994; 81: 820-828.
120. Stanley TH, Gray NG, Stanford W, Armstrong R. The effects of high-dose morphine on fluid and blood requirements in open-heart operations. Anesthesiology 1973; 38: 536-541.
121. Stanley TH, Lathrop GD. Urinary excretion of morphine during and after valvular and coronary-artery surgery. Anesthesiology 1977; 46: 166-169.
122. Szeto HH, Inturrisi CE, Houde R, Saal S, Cheigh J, Reidenberg M. Accumulation of normeperidine, an active metabolite of meperidine in patients with renal failure or cancer. Annals of Internal Medicine 1977; 86: 738-741.
123. Taeger K, Weninger E, Schmelzer F, Adt M, Franke N, Peter K. Pulmonary kinetics of fentanyl and alfentanil in surgical patients. British Journal of Anaesthesia 1988; 61: 425-434.
124. Tamsen A, Hartvig P, Dahlstrom B, Fagerlund C. Patient-controlled analgesia therapy. I Pharmacokinetics of pethidine in the peroperative and perioperative periods. Clinical Pharmacokinetics 1982; 7: 149-163.
125. van Beem H, van Peer A, Gasparini R, Woestenborghs R, Heykants J, Noorduin H, Van Egmond J, Crul J. Pharmacokinetics of alfentanil during and after a fixed rate infusion. British Journal of Anaesthesia 1989; 62: 610-615.
126. Vinik HR, Bradley EL, Kissin I. Midazolam-alfentanil synergism for anesthetic induction in patients. Anesthesia and Analgesia 1989; 69: 213-217.
127. Vinik HR, Bradley EL, Kissin I, Triple anesthetic combination: propofol-midazolam-alfentanil. Anesthesia and Analgesia 1994; 78: 354-358.
128. Vuyk J, Hennis PJ, Burm AGL, de Voogt JWH, Spierdijk J. Comparison of midazolam and propofol in combination with alfentanil for total intravenous anesthesia. Anesthesia and Analgesia 1990; 71: 645-650.
129. Vuyk J, Lim T, Engbers FHM, Burm AGL, Vletter AA, Bovill JG. Pharmacodynamics of alfentanil as a supplement to propofol or nitrous oxide for lower abdominal surgery in female patients. Anesthesiology 1993; 78: 1036-1045.
130. Vuyk J, Lim T, Engbers FHM, Burm AGL, Vletter AA, Bovill JG. The pharmacodynamic interaction of propofol and alfentanil during lower abdominal surgery in women. Anesthesiology 1995; 83: 8-22.
131. Westmorland CL, Sebel PS, Gropper A. Fentanyl or alfentanil decreases the minimum alveolar concentration of isoflurane in surgical patients. Anesthesia and Analgesia 1994; 78: 23-28.
132. Wiggum DC, Cork RC, Weldon ST, Gandolfi AJ, Perry DS. Postoperative respiratory depression and elevated sufentanil levels in a patient with chronic renal failure. Anesthesiology 1985; 63: 708-710.
133. Woolner DF, Winter D, Frendin TJ, Begg EJ, Lynn KL, Wright GJ. Renal failure does not impair the metabolism of morphine. British Journal of Clinical Pharmacology 1986; 22: 55-59.
134. Youngs EJ, Shafer SL. Pharmacokinetic parameters relevant to recovery from opioids. Anesthesiology 1994; 81: 833-842.